TRZ
TRZ is a synthetic peptide analog studied for its ability to activate both the glucose-dependent insulinotropic polypeptide (GIP) receptor and the GLP-1 receptor. Known in the scientific literature as a “dual incretin receptor agonist,” it has been widely researched for its role in metabolic signaling pathways, energy balance studies, and endocrine-related mechanisms.
GIP Receptor Pathway (GIPR)
Studies describe GIPR activation as influencing:
- cAMP/PKA intracellular signaling
- stimulation of insulin secretion (model systems)
- β-cell function and anti-apoptotic signaling
- energy-balance pathways
GLP-1 Receptor Pathway (GLP-1R)
Published research notes involvement in:
- GLP-1 mediated signaling cascades
- effects on gastric emptying models
- hypothalamic appetite-signaling circuits
- modulation of glucagon-related pathways
$120.00
Per Unit
In stock